• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌和痰炎症细胞计数;COPD 队列分析。

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis.

机构信息

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9QZ, UK.

出版信息

Respir Res. 2020 Nov 1;21(1):289. doi: 10.1186/s12931-020-01552-4.

DOI:10.1186/s12931-020-01552-4
PMID:33131502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7603729/
Abstract

BACKGROUND

There is evidence that bacterial colonisation in chronic obstructive pulmonary disease (COPD) is associated with increased neutrophilic airway inflammation. This study tested the hypothesis that different bacterial phyla and species cause different inflammatory profiles in COPD patients.

METHODS

Sputum was analysed by quantitative polymerase chain reaction (qPCR) to quantify bacterial load and 16S rRNA gene sequencing to identify taxonomic composition. Sputum differential cell counts (DCC) and blood DCC were obtained at baseline and 6 months. Patients were categorised into five groups based on bacterial load defined by genome copies/ml of ≥ 1 × 10, no colonisation and colonisation by Haemophilus influenzae (H. influenzae), Moraxella catarrhalis (M. catarrhalis), Streptococcus pneumoniae (S. pneumoniae), or > 1 potentially pathogenic microorganism (PPM).

RESULTS

We observed an increase in sputum neutrophil (%), blood neutrophil (%) and neutrophil-lymphocyte ratio (NLR) in patients colonised with H. influenzae (82.6, 67.1, and 3.29 respectively) compared to those without PPM colonisation at baseline (69.5, 63.51 and 2.56 respectively) (p < 0.05 for all analyses), with similar findings at 6 months. The bacterial load of H. influenzae and Haemophilus determined by qPCR and 16s rRNA gene sequencing respectively, and sputum neutrophil % were positively correlated between baseline and 6 months visits (p < 0.0001, 0.0150 and 0.0002 with r = 0.53, 0.33 and 0.44 respectively).

CONCLUSIONS

These results demonstrate a subgroup of COPD patients with persistent H. influenzae colonisation that is associated with increased airway and systemic neutrophilic airway inflammation, and less eosinophilic airway inflammation.

摘要

背景

有证据表明,慢性阻塞性肺疾病(COPD)中的细菌定植与中性粒细胞性气道炎症增加有关。本研究检验了这样一个假设,即不同的细菌门和种属在 COPD 患者中引起不同的炎症特征。

方法

通过定量聚合酶链反应(qPCR)分析痰标本以量化细菌负荷,并通过 16S rRNA 基因测序来鉴定分类组成。在基线和 6 个月时获得痰细胞分类计数(DCC)和血液 DCC。根据基因组拷贝数/ml 定义的细菌负荷将患者分为五组,≥1×10、无定植和定植于流感嗜血杆菌(H. influenzae)、卡他莫拉菌(M. catarrhalis)、肺炎链球菌(S. pneumoniae)或>1 种潜在致病微生物(PPM)。

结果

与无 PPM 定植的患者相比,定植于 H. influenzae 的患者(分别为 82.6%、67.1%和 3.29%)的痰中性粒细胞(%)、血液中性粒细胞(%)和中性粒细胞-淋巴细胞比值(NLR)增加(所有分析 p<0.05),6 个月时也有类似发现。qPCR 和 16s rRNA 基因测序分别确定的 H. influenzae 细菌负荷和痰中性粒细胞%在基线和 6 个月时呈正相关(p<0.0001、0.0150 和 0.0002,r=0.53、0.33 和 0.44)。

结论

这些结果表明,COPD 患者中有一部分持续定植于 H. influenzae,这与气道和全身中性粒细胞性气道炎症增加以及较少的嗜酸性粒细胞性气道炎症有关。

相似文献

1
Bacteria and sputum inflammatory cell counts; a COPD cohort analysis.细菌和痰炎症细胞计数;COPD 队列分析。
Respir Res. 2020 Nov 1;21(1):289. doi: 10.1186/s12931-020-01552-4.
2
Airway Bacteria Quantification Using Polymerase Chain Reaction Combined with Neutrophil and Eosinophil Counts Identifies Distinct COPD Endotypes.使用聚合酶链反应结合中性粒细胞和嗜酸性粒细胞计数进行气道细菌定量可识别不同的慢性阻塞性肺疾病(COPD)内型。
Biomedicines. 2021 Sep 27;9(10):1337. doi: 10.3390/biomedicines9101337.
3
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.通过定量聚合酶链反应和培养法测定稳定期慢性阻塞性肺疾病患者气道细菌:与中性粒细胞性气道炎症、急性加重频率及肺功能的关系
Int J Chron Obstruct Pulmon Dis. 2015 Jun 9;10:1075-83. doi: 10.2147/COPD.S80091. eCollection 2015.
4
Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.使用定量聚合酶链反应检测到的病原体与慢性阻塞性肺疾病稳定期气道炎症及急性加重之间的关联。
Chest. 2015 Jan;147(1):46-55. doi: 10.1378/chest.14-0764.
5
COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species.慢性阻塞性肺疾病的特征是流感嗜血杆菌、肺炎链球菌检测率增加,以及芽孢杆菌属缺乏。
Respirology. 2016 May;21(4):697-704. doi: 10.1111/resp.12734. Epub 2016 Jan 18.
6
Blood and sputum eosinophils in COPD; relationship with bacterial load.慢性阻塞性肺疾病中的血液和痰液嗜酸性粒细胞;与细菌载量的关系。
Respir Res. 2017 May 8;18(1):88. doi: 10.1186/s12931-017-0570-5.
7
Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病的炎症阈值及定植细菌的种属特异性效应
Respir Res. 2014 Sep 14;15(1):114. doi: 10.1186/s12931-014-0114-1.
8
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.细菌定植与慢性阻塞性肺疾病(COPD)急性加重的频率、特征及严重程度之间的关系。
Thorax. 2002 Sep;57(9):759-64. doi: 10.1136/thorax.57.9.759.
9
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.慢性阻塞性肺疾病患者在疾病稳定期长期被流感嗜血杆菌定植,其气道炎症会加重。
Int J Chron Obstruct Pulmon Dis. 2015 May 4;10:881-9. doi: 10.2147/COPD.S78748. eCollection 2015.
10
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.左氧氟沙星对稳定期 COPD 中性粒细胞气道炎症的影响:一项随机、双盲、安慰剂对照试验。
Int J Chron Obstruct Pulmon Dis. 2014 Feb 7;9:179-86. doi: 10.2147/COPD.S55419. eCollection 2014.

引用本文的文献

1
Correlation of Neutrophil-Lymphocyte Ratio and Critical Illness in Adults on Vancomycin: A Cross-Sectional Study.成人使用万古霉素时中性粒细胞与淋巴细胞比值与危重病的相关性:一项横断面研究。
Int J Gen Med. 2025 Jul 31;18:4157-4167. doi: 10.2147/IJGM.S537039. eCollection 2025.
2
Chronic Obstructive Pulmonary Disease (COPD): Developments in Pharmacological Treatments.慢性阻塞性肺疾病(COPD):药物治疗的进展
Drugs. 2025 May 20. doi: 10.1007/s40265-025-02188-8.
3
Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study.

本文引用的文献

1
The sputum microbiome is distinct between COPD and health, independent of smoking history.痰微生物组在 COPD 和健康之间存在差异,与吸烟史无关。
Respir Res. 2020 Jul 14;21(1):183. doi: 10.1186/s12931-020-01448-3.
2
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病临床试验中的血液嗜酸性粒细胞计数
Am J Respir Crit Care Med. 2020 Sep 1;202(5):660-671. doi: 10.1164/rccm.201912-2384PP.
3
Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis.
日本慢性阻塞性肺疾病(COPD)合并中度气流受限患者的痰液微生物组、潜在致病生物与临床结局:前瞻性AERIS-J研究
Int J Chron Obstruct Pulmon Dis. 2025 May 14;20:1477-1492. doi: 10.2147/COPD.S481406. eCollection 2025.
4
Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial.重新思考血嗜酸性粒细胞在 COPD 患者评估吸入性皮质类固醇反应中的作用:来自 FLAME 试验的事后分析。
Chest. 2024 Nov;166(5):987-997. doi: 10.1016/j.chest.2024.06.3790. Epub 2024 Jul 9.
5
The human lung microbiome-A hidden link between microbes and human health and diseases.人类肺部微生物群——微生物与人类健康和疾病之间的隐藏联系。
Imeta. 2022 Jun 16;1(3):e33. doi: 10.1002/imt2.33. eCollection 2022 Sep.
6
Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者气道微生物组的人类遗传相关性研究。
Respir Res. 2024 Apr 16;25(1):165. doi: 10.1186/s12931-024-02805-2.
7
Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation.探讨肠道-肺相互作用在慢性阻塞性肺疾病发病机制中的作用:关于微生物群特征和炎症调节的综合综述
Chronic Obstr Pulm Dis. 2024 May 29;11(3):311-325. doi: 10.15326/jcopdf.2023.0442.
8
High Blood Eosinophil Count at Stable State is Not Associated with Airway Microbiota Distinct Profile in COPD.稳定期高血嗜酸性粒细胞计数与 COPD 患者气道微生物群特征无明显相关性。
Int J Chron Obstruct Pulmon Dis. 2024 Mar 18;19:765-771. doi: 10.2147/COPD.S453526. eCollection 2024.
9
How inhaled corticosteroids target inflammation in COPD.吸入性皮质类固醇如何靶向 COPD 中的炎症。
Eur Respir Rev. 2023 Oct 18;32(170). doi: 10.1183/16000617.0084-2023. Print 2023 Dec 31.
10
Early diagnostic BioMARKers in exacerbations of chronic obstructive pulmonary disease: protocol of the exploratory, prospective, longitudinal, single-centre, observational MARKED study.慢性阻塞性肺疾病加重期的早期诊断生物标志物:探索性、前瞻性、纵向、单中心、观察性 MARKED 研究方案。
BMJ Open. 2023 Mar 3;13(3):e068787. doi: 10.1136/bmjopen-2022-068787.
吸入性类固醇、循环嗜酸性粒细胞、慢性气道感染与慢性阻塞性肺疾病肺炎风险:网络分析。
Am J Respir Crit Care Med. 2020 May 1;201(9):1078-1085. doi: 10.1164/rccm.201908-1550OC.
4
The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives.慢性阻塞性肺疾病(COPD)稳定期和加重期肺部微生物组动态变化:当前观点。
Respir Med. 2019 Oct;157:1-6. doi: 10.1016/j.rmed.2019.08.012. Epub 2019 Aug 21.
5
Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease.循环中性粒细胞水平是慢性阻塞性肺疾病肺炎风险的预测因子。
Respir Res. 2019 Aug 23;20(1):195. doi: 10.1186/s12931-019-1157-0.
6
Airway host-microbiome interactions in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的气道宿主-微生物组相互作用。
Respir Res. 2019 Jun 6;20(1):113. doi: 10.1186/s12931-019-1085-z.
7
Biomarkers in Pneumonia-Beyond Procalcitonin.肺炎的生物标志物:降钙素原之外
Int J Mol Sci. 2019 Apr 24;20(8):2004. doi: 10.3390/ijms20082004.
8
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
9
A time for everything and everything in its time - exploring the mechanisms underlying seasonality of COPD exacerbations.万物皆有时,时来不可失——探索慢性阻塞性肺疾病急性加重季节性背后的机制。
Int J Chron Obstruct Pulmon Dis. 2018 Sep 5;13:2739-2749. doi: 10.2147/COPD.S146015. eCollection 2018.
10
Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.生物恶化簇显示哮喘和慢性阻塞性肺疾病具有重叠特征,其介质和微生物组特征也不同。
J Allergy Clin Immunol. 2018 Jun;141(6):2027-2036.e12. doi: 10.1016/j.jaci.2018.04.013. Epub 2018 Apr 28.